Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The small single-site study will need to be replicated in a larger group of adolescents.
Better integration and transition planning was associated with higher rates of viral suppression among youth with HIV.
Supporting universal access to care and quality-of-life check-ins may be associated with better quality of life for teens with HIV.
The Pfizer-BioNTech vaccine was 100% effective in a study of adolescents; trials for younger children are now underway.
Study also finds that trans girls are more likely to receive gender-affirming care than trans boys.
Iris House encourages young people to get tested.
However, even as new cases climbed, deaths declined.
Compared with efavirenz-based regimens, dolutegravir-containing ones resulted in fewer switches and better viral control.
The number of days to an undetectable viral load dropped by nearly two weeks, but there’s more work to do.
An HIV prevention roundup
Globally, a child contracts HIV every 100 seconds. A new, affordable treatment is available, but the COVID-19 pandemic hinders access.
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.
Researchers used mathematical modeling to analyze the projected benefits of more frequent HIV testing in this population.
A recent NIH study found that adults have a much higher viral suppression rate than youth.
The CDC has issued a report detailing considerations for clinicians prescribing PrEP for this population.
The association between viral load and cardiovascular disease risk has been under-investigated among young people with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.